| Filed On | Filing |
|---|---|
| 06 May 2026 |
Form 4: PureTech Health plc, 10% owner and 1 other · Seaport Therapeutics Inc
Received 16,382,534 shares by conversion |
| 08 Jul 2024 |
Form 4: PureTech Health plc, 10% owner and 1 other · Akili, Inc.
Disposed of 12,527,477 shares (Tender Offer) |
| 21 Sep 2023 |
Form 4: PureTech Health plc, 10% owner and 1 other · GELESIS HOLDINGS, INC.
Acquired 0 Convertible Note (Open Market Purchase) |
| 14 Jun 2023 |
Form 4: PureTech Health plc, 10% owner and 1 other · GELESIS HOLDINGS, INC.
Acquired 0 Convertible Note (Open Market Purchase) |
| 31 May 2023 |
Form 4: PureTech Health plc, 10% owner and 1 other · GELESIS HOLDINGS, INC.
Acquired 0 Convertible Note (Open Market Purchase) · Acquired 43,133,803 Warrants (Open Market Purchase) |
| 03 May 2023 |
Form 4: PureTech Health plc, 10% owner and 1 other · GELESIS HOLDINGS, INC.
Acquired 7,000,000 Convertible Note (Open Market Purchase) ($29T) · Acquired 215,995,739 Warrants (Open Market Purchase) |
Loading...
